News Release(2019)

December 9, 2019

Positive Results from Uterine Fibroids Phase-III PRIMROSE 2 Trial of Linzagolix

November 26, 2019

Positive Topline Data from Pivotal Phase-III ADVOCATE Trial Demonstrating Avacopan's Superiority over Standard of Care in ANCA Vasculitis

November 26, 2019

Launch of "Darbepoetin Alfa BS Injection [JCR]" for the Treatment of Renal Anemia

September 20, 2019

Kissei Initiates Phase III Clinical Trial for Fostamatinib in Japanese Patients with Chronic Idiopathic Thrombocytopenic Purpura

September 20, 2019

JCR Receives Marketing Approval in Japan for Darbepoetin Alfa BS Injection JCR, a Long-Acting Erythropoiesis-Stimulating Agent

September 19, 2019

Launch of MINIRIN MELT® OD tablet 25µg and 50µg for the Treatment of Nocturia due to Nocturnal Polyuria in Males

June 18, 2019

Announcement of Co-promotion Agreement and Marketing Authorization Approval in Japan for MINIRIN MELT® OD Tablet 25µg and 50µg for Treatment of Nocturia due to Nocturnal Polyuria in Males

June 13, 2019

Launch of GLUBES® Combination Orally Disintegrating Tablet, a Rapid-acting Insulin Secretagogue and Agent for Postprandial Hyperglycemia